| Surfactant and the neonatal lung. | |
| | |
MedLine Citation:
|
PMID: 9509038 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Deficiency of pulmonary surfactant is responsible for a substantial proportion of the mortality and morbidity in infants born prematurely. Surfactant replacement therapy has been extensively investigated and has become a central part of neonatal intensive care in the UK over the last 3 years. Evidence for the efficacy of this treatment is provided as is a discussion of the different surfactant preparations available and different protocols for administration. |
| | |
Authors:
|
A T Gibson |
Related Documents
:
|
22319588 - Influence of milk-feeding type and genetic risk of developing coeliac disease on intest... 20853568 - Respiratory illness in late preterm infants during the first six months of life. 9039518 - Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respi... 3840268 - Respiratory distress syndrome treated with human surfactant: radiographic findings. 353238 - Intermittent bag ventilation of preterm infants on continuous positive airway pressure:... 12776248 - Congenital fibrosarcoma of the jejunum in a premature infant with meconium peritonitis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: British journal of hospital medicine Volume: 58 ISSN: 0007-1064 ISO Abbreviation: Br J Hosp Med Publication Date: 1997 Oct 15-Nov 4 |
Date Detail:
|
Created Date: 1998-04-03 Completed Date: 1998-04-03 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0171545 Medline TA: Br J Hosp Med Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 381-4, 397 Citation Subset: IM |
Affiliation:
|
Jessop Hospital for Women, Sheffield. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Clinical Protocols Cost-Benefit Analysis Female Humans Infant, Newborn Male Pulmonary Surfactants* / deficiency, metabolism, therapeutic use Randomized Controlled Trials as Topic Respiratory Distress Syndrome, Newborn / drug therapy*, mortality Surface-Active Agents / administration & dosage, economics, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Pulmonary Surfactants; 0/Surface-Active Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Provision of paediatric intensive care services.
Next Document: Economics of vascular surgery.